Identification of Rhodococcus equi lipids recognized by host cytotoxic T lymphocytes

Microbiology

Volumn 156, Issue 6, 2010, Pages 1836-1847

  Harris, Seth P ^a   Fujiwara, Nagatoshi ^b   Mealey, Robert H ^a   Alperin, Debra C ^a   Naka, Takashi ^b   Goda, Reina ^b   Hines, Stephen A ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; BACTERIAL ANTIGEN; CARDIOLIPIN; CD8 ANTIGEN; CORD FACTOR; EQUINE LYMPHOCYTE ALLOANTIGEN A; GAMMA INTERFERON; GLYCOLIPID; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE LIPID; MESSENGER RNA; PROTEINASE; TREHALOSE MONOMYCOLATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL IMMUNITY; CD8+ T LYMPHOCYTE; CELL STIMULATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; GENETIC TRANSCRIPTION; HORSE; HOST PATHOGEN INTERACTION; LIPID ANALYSIS; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RHODOCOCCUS EQUI; THIN LAYER CHROMATOGRAPHY; TIME OF FLIGHT MASS SPECTROMETRY;

ANIMALS; ANTIGENS, BACTERIAL; CELL WALL; HORSES; INTERFERON-GAMMA; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; LIPIDS; RHODOCOCCUS EQUI; T-LYMPHOCYTES, CYTOTOXIC;

EID: 77953198672     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.035915-0     Document Type: Article

References (53)

1. Beckman, E. M., Porcelli, S. A., Morita, C. T., Behar, S. M., Furlong, S. T. & Brenner, M. B. (1994). Recognition of a lipid antigen by CD1-restricted αβ+ T cells. Nature 372, 691-694.
2. Bhatt, A., Fujiwara, N., Bhatt, K., Gurcha, S. S., Kremer, L., Chen, B., Chan, J., Porcelli, S. A., Kobayashi, K. & other authors (2007). Deletion of kasB in Mycobacterium tuberculosis causes loss of acidfastness and subclinical latent tuberculosis in immunocompetent mice. Proc Natl Acad Sci U S A 104, 5157-5162.
3. Boom, W. H., Canaday, D. H., Fulton, S. A., Gehring, A. J., Rojas, R. E. & Torres, M. (2003). Human immunity to M. tuberculosis: T cell subsets and antigen processing. Tuberculosis (Edinb) 83, 98-106.
4. Brennan, P. J. & Nikaido, H. (1995). The envelope of mycobacteria. Annu Rev Biochem 64, 29-63.
5. Bricard, G. & Porcelli, S. A. (2007). Antigen presentation by CD1 molecules and the generation of lipid-specific T cell immunity. Cell Mol Life Sci 64, 1824-1840.
6. Brigl, M. & Brenner, M. B. (2004). CD1: antigen presentation and T cell function. Annu Rev Immunol 22, 817-890.
7. + T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligandindependent mechanism. J Immunol 167, 2734-2742.
8. Catucci, L., Depalo, N., Lattanzio, V. M., Agostiano, A. & Corcelli, A. (2004). Neosynthesis of cardiolipin in Rhodobacter sphaeroides under osmotic stress. Biochemistry 43, 15066-15072.
9. Dascher, C. C., Hiromatsu, K., Xiong, X., Morehouse, C., Watts, G., Liu, G., McMurray, D. N., LeClair, K. P., Porcelli, S. A. & Brenner, M. B. (2003). Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis. Int Immunol 15, 915-925.
10. Dittmer, J. C. & Lester, R. L. (1964). A simple, specific spray for the detection of phospholipids on thin-layer chromatograms. J Lipid Res 15, 126-127.
11. Fischer, K., Chatterjee, D., Torrelles, J., Brennan, P. J., Kaufmann, S. H. E. & Schaible, U. E. (2001). Mycobacterial lysocardiolipin is exported from phagosomes upon cleavage of cardiolipin by a macrophage-derived lysosomal phospholipase A2. J Immunol 167, 2187-2192. (Pubitemid 32747529)
12. Folch, J., Lees, M. & Sloane Stanley, G. H. (1957). A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497-509.
13. + T lymphocytes in control of Mycobacterium tuberculosis infection. Microbes Infect 7, 776-788.
14. Hava, D. L., Brigl, M., van den Elzen, P., Zajonc, D. M., Wilson, I. A. & Brenner, M. B. (2005). CD1 assembly and the formation of CD1-antigen complexes. Curr Opin Immunol 17, 88-94.
15. Hines, M. T., Paasch, K. M., Alperin, D. C., Palmer, G. H., Westhoff, N. C. & Hines, S. A. (2001). Immunity to Rhodococcus equi: antigenspecific recall responses in the lungs of adult horses. Vet Immunol Immunopathol 79, 101-113.
16. + T lymphocytes. Clin Diagn Lab Immunol 10, 208-215.
17. Hiromatsu, K., Dascher, C. C., Leclair, K. P., Sugita, M., Furlong, S. T., Brenner, M. B. & Porcelli, S. A. (2002). Induction of CD1-restricted immune responses in guinea pigs by immunization with mycobacterial lipid antigens. J Immunol 169, 330-339. (Pubitemid 34686153)
18. Hondalus, M. K. (1997). Pathogenesis and virulence of Rhodococcus equi. Vet Microbiol 56, 257-268.
19. Hooper-McGrevy, K. E., Wilkie, B. N. & Prescott, J. F. (2005). Virulence-associated protein-specific serum immunoglobulin Gisotype expression in young foals protected against Rhodococcus equi pneumonia by oral immunization with virulent R. equi. Vaccine 23, 5760-5767.
20. + T-lymphocyte-deficient transgenic mice. Infect Immun 61, 4929-4932.
21. Kanaly, S. T., Hines, S. A. & Palmer, G. H. (1995). Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia. Infect Immun 63, 3037-3041.
22. + Th1 cell line to nude mice effects clearance of Rhodococcus equi from the lung. Infect Immun 64, 1126-1132.
23. Karakousis, P. C., Bishai, W. R. & Dorman, S. E. (2004). Mycobacterium tuberculosis cell envelope lipids and the host immune response. Cell Microbiol 6, 105-116.
24. Kurano, S., Sugimoto, N., Sumi, Y., Sawai, H., Kato, Y., Kaneda, K. & Yano, I. (1987). Newly isolated glycolipids from Rhodococcus terrae cell wall and their granuloma forming activities. Yakugaku Zasshi 107, 46-52.
25. Li, B., Rossman, M. D., Imir, T., Fusun Oner-Eyuboglu, A., Wa Lee, C., Biancaniella, R. & Carding, S. R. (1996). Disease-specific changes in cd T cell repertoire and function in patients with pulmonary tuberculosis. J Immunol 157, 4222-4229. (Pubitemid 126449337)
26. Linder, R. (1997). Rhodococcus equi and Arcanobacterium haemolyticum: two 'coryneform' bacteria increasingly recognized as agents of human infection. Emerg Infect Dis 3, 145-153.
27. Lopez, A. M., Hines, M. T., Palmer, G. H., Alperin, D. C. & Hines, S. A. (2002). Identification of pulmonary T-lymphocyte and serum antibody isotype responses associated with protection against Rhodococcus equi. Clin Diagn Lab Immunol 9, 1270-1276.
28. + cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins. J Virol 68, 1459-1467.
29. Moody, D. B. & Porcelli, S. A. (2003). Intracellular pathways of CD1 antigen presentation. Nat Rev Immunol 3, 11-21.
30. Moody, D. B., Reinhold, B. B., Reinhold, V. N., Besra, G. S. & Porcelli, S. A. (1999). Uptake and processing of glycosylated mycolates for presentation to CD1b-restricted T cells. Immunol Lett 65, 85-91.
31. Moody, D. B., Briken, V., Cheng, T.-Y., Roura-Mir, C., Guy, M. R., Geho, D. H., Tykocinski, M. L., Besra, G. S. & Porcelli, S. A. (2002). Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation. Nat Immunol 3, 435-442.
32. Natsuhara, Y., Yoshinaga, J., Shogaki, T., Sumi-Nishikawa, Y., Kurano, S., Kato, Y., Kaneda, K., Oka, S. & Yano, I. (1990). Granuloma-forming activity and antitumor activity of newly isolated mycoloyl glycolipid from Rhodococcus terrae 70012 (Rt. GM-2). Microbiol Immunol 34, 45-53. (Pubitemid 20094082)
33. Nishiuchi, Y., Baba, T. & Yano, I. (2000). Mycolic acids from Rhodococcus, Gordonia, and Dietzia. J Microbiol Methods 40, 1-9.
34. + T lymphocytes in a MHC class I-unrestricted fashion. Infect Immun 72, 7073-7083.
35. Patton, K. M., McGuire, T. C., Hines, M. T., Mealey, R. H. & Hines, S. A. (2005). Rhodococcus equi-specific cytotoxic T lymphocytes in immune horses and development in asymptomatic foals. Infect Immun 73, 2083-2093.
36. Perez, M. G. V., Vassilev, T. & Kemmerly, S. A. (2002). Rhodococcus equi infection in transplant recipients: a case of mistaken identity and review of the literature. Transpl Infect Dis 4, 52-56.
37. Porcelli, S. A. (2001). Cutting glycolipids down to size. Nat Immunol 2, 191-192.
38. Rahman, M. T., Herron, L. L., Kapur, V., Meijer, W. G., Byrne, B. A., Ren, J., Nicholson, V. M. & Prescott, J. F. (2003). Partial genome sequencing of Rhodococcus equi ATCC 33701. Vet Microbiol 94, 143-158.
39. Rao, V., Fujiwara, N., Porcelli, S. A. & Glickman, M. S. (2005). Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule. J Exp Med 201, 535-543.
40. Roura-mir, C. & Moody, D. B. (2003). Sorting out self and microbial lipid antigens for CD1. Microbes Infect 5, 1137-1148.
41. + CTL from lungs of Mycobacterium tuberculosis-infectedmice express perforin in vivo and lyse infected macrophages. J Immunol 165, 353-363.
42. Siliciano, R. F., Keegan, A., Dintzis, R., Dintzis, H. & Shin, H. (1985). The interaction of nominal antigen with T cell antigen receptors. I. Specific binding of multivalent nominal antigen to cytolytic T cell clones. J Immunol 135, 906-914. (Pubitemid 16242775)
43. + cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis. Infect Immun 65, 4525-4530.
44. Stenger, S. & Modlin, R. L. (1999). T cell mediated immunity to Mycobacterium tuberculosis. Curr Opin Microbiol 2, 89-93.
45. Szereday, L., Baliko, Z. & Szekeres-Bartho, J. (2003). γ/δ T cell subsets in patients with active Mycobacterium tuberculosis infection and tuberculin anergy. Clin Exp Immunol 131, 287-291.
46. Takai, S. (1997). Epidemiology of Rhodococcus equi infections: a review. Vet Microbiol 56, 167-176.
47. Tonge, P. J. (2000). Another brick in the wall. Nat Struct Biol 7, 94-96.
48. Torres-Tortosa, M., Arrizabalaga, J., Villanueva, J. L., Gálvez, J., Leyes, M., Valencia, M. E., Flores, J., Peña, J. M., Pérez-Cecilia, E. & other authors (2003). Prognosis and clinical evaluation of infection caused by Rhodococcus equi in HIV-infected patients. Chest 123, 1970-1976.
49. Ueda, S., Fujiwara, N., Naka, T., Sakaguchi, Y., Ozeki, I. & Yano, T. (2001). Structure-activity relationship of mycoloyl glycolipids derived from Rhodococcus sp. 4306. Microb Pathog 30, 91-99.
50. Ulrichs, T., Moody, D. B., Grant, E., Kaufmann, S. H. E. & Porcelli, S. A. (2003). T-cell responses to CD1-presented lipid antigen in humans with Mycobacterium tuberculosis infection. Infect Immun 71, 3076-3087.
51. Willcox, B. E., Willcox, C., Dover, L. & Besra, G. S. (2007). Structures and functions of microbial lipid antigens presented by CD1. Curr Top Microbiol Immunol 314, 73-110.
52. Zhang, W., Lonning, S. M. & McGuire, T. C. (1998). Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection. J Virol 72, 9612-9620. (Pubitemid 28520824)
53. Zinner, S. H. (1999). Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on Gram-positive and resistant bacteria. Clin Infect Dis 29, 490-494.